PBM/Manufacturer Therapeutic Substitution Contracts Sought In FTC Study
Executive Summary
The Federal Trade Commission is asking pharmacy benefit management companies to submit their "therapeutic substitution" contracts with pharmaceutical manufacturers as part of a study of "conflicts of interest" in the PBM sector